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Abstract 
Rationale 
It is becoming increasingly clear that the development of treatments for 
cognitive symptoms of schizophrenia requires urgent attention, and that valid 
animal models of relevant impairments are required.  With subchronic PCP 
(scPCP) a putative model of such impairment, the extent to which changes 
following scPCP do or do not resemble those following dysfunction of the 
prefrontal cortex is of importance. 
Objectives 
The present study carried out a comparison of the most common scPCP 
dosing regimen with excitotoxin-induced medial prefrontal cortex (mPFC) 
dysfunction in the rat, across several cognitive tests relevant to schizophrenia. 
Methods 
ScPCP subjects were dosed i.p. with 5mg/kg PCP or vehicle twice daily for 
one week followed by 1 week washout prior to behavioural testing.  mPFC 
dysfunction was induced via fibre-sparing excitotoxin infused into the 
prelimbic and infralimbic cortex.  Subjects were tested on spontaneous novel 
object recognition, touchscreen object-location paired-associates learning, 
and touchscreen reversal learning. 
Results 
A double-dissociation was observed between object-location paired-
associates learning and object recognition: mPFC dysfunction impaired 
acquisition of the object-location task, but not spontaneous novel object 
recognition, while scPCP impaired spontaneous novel object recognition, but 
not object-location associative learning. Both scPCP and mPFC dysfunction 
resulted in a similar facilitation of reversal learning. 
Conclusions 
The pattern of impairment following scPCP raises questions around its 
efficacy as a model of cognitive impairment in schizophrenia, particularly if 
importance is placed on faithfully replicating the effects of mPFC dysfunction. 
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Introduction 
 
It is becoming increasingly clear that the development of treatments for 
the cognitive symptoms of schizophrenia requires urgent attention 
(Minzenberg and Carter 2012; Schaefer et al. 2013; Vingerhoets et al. 2013).  
To achieve this aim we need valid animal models of the cognitive impairments 
in schizophrenia (Nestler and Hyman 2010).  The psychotomimetic agent 
phencyclidine (PCP) has been widely used to model schizophrenia in rodents 
(Castner et al. 2004; Neill et al. 2010).  In humans, PCP and other N-methyl-
D-aspartate receptor (NMDAR) antagonists can induce the symptoms of 
schizophrenia and cause relapse for schizophrenics stabilized on anti-
psychotic medication (Itil et al. 1967; Javitt and Zukin 1991; Krystal et al. 
1994; Lahti et al. 1995 & 2001; Malhotra et al. 1996 & 1997; Snyder 1980; 
Tamminga 1998).  These observations are consistent with the ‘glutamate 
hypothesis of schizophrenia’, which posits that NMDAR function is disrupted 
in schizophrenia (Javitt et al. 2012; Poels et al. 2014; Singh and Singh 2011).   
Subchronic PCP (scPCP) in particular has many prima facie 
advantages. For example, cognitive impairments relevant to schizophrenia 
have been observed following scPCP (Arnt et al. 2010; Barnes et al. 2012; 
Beninger et al. 2010; Howes et al. 2015; Laurent and Podhorna 2004; 
McKibben et al. 2010; Meltzer et al. 2013) and the model, like other 
subchronic treatments, allows assessment of the effects of the treatment 
when the drug is no longer ‘on board’, thus minimizing motoric and/or 
motivational changes which can seriously confound cognitive testing and 
subsequent interpretation of the results.  
Another attraction of the scPCP model is the assumption that it induces 
dysfunction of the prefrontal cortex (Amitai et al. 2012; Young et al. 2015), a 
major feature of the schizophrenic brain often cited as a major contributor to 
cognitive deficits (Glahn et al. 2005; Hill et al. 2004; Ingvar and Franzen 
1974).  Therefore the extent to which changes following scPCP do or do not 
resemble those found following dysfunction of the prefrontal cortex is of some 
importance to researchers in this area. Therefore in the present study we 
carried out a head-to-head comparison of the effects of the most common 
scPCP dosing regimen (5mg/kg twice daily for seven days followed by 7 days 
washout), with the effects of fibre-sparing excitotoxin-induced medial 
prefrontal cortex (mPFC) dysfunction in the rat, across several cognitive tests 
relevant to schizophrenia: object-location paired-associates learning, 
spontaneous novel object recognition, and reversal learning.   
 Object-location learning (Experiment 1):Object-location learning, for 
example as studied using the CANTAB PAL test (Sahakian et al. 1988), can 
be used to investigate the MATRICS domain of visual learning and memory 
and the CNTRICS domain of long term memory.  Impairments in object-
location paired-associates learning (PAL) have been found in chronic 
schizophrenia (Aubin et al. 2009; Donohoe et al. 2008; Haring et al. 2014; 
Wood et al. 2002) and can also be present at first onset of the disorder and 
may predict following clinical severity (Barnett et al. 2005).  Additionally, 
impairments on CANTAB PAL have been observed during the prodromal 
phase and may be present in relatives at risk of developing schizophrenia 
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(Bartok et al. 2005).  Normal performance of CANTAB PAL depends on the 
medial temporal lobe (Wood et al. 2002) and prefrontal cortex (Owen et al. 
1995).   
 The rodent object-location paired-associates learning task (PAL) was 
inspired by the CANTAB PAL task (Talpos et al. 2009) and has been 
recommended by CNTRICS for studying long-term memory in animal models 
of schizophrenia (Bussey et al. 2013).   
 Object Recognition (Experiment 2). Spontaneous Object Recognition 
(SOR) has been used to examine non-spatial memory impairments linked to 
schizophrenia (Dere et al. 2007; Lyon et al. 2012).  In studies of SOR and 
scPCP immediately post-washout, significant impairments were observed 
following various retention periods (Arnt et al. 2010; Horiguchi et al. 2011; 
McKibben et al. 2010; Snigdha et al. 2010).  Additionally, object recognition 
impairments following scPCP are attenuated by clozapine and risperidone, 
but not haloperidol (Grayson et al. 2007).   
 Reversal Learning (Experiment 3): Reversal learning assesses the 
subject’s ability to acquire a simple ‘rule’ and then adopt a new strategy when 
the rule no longer holds. Reversal learning is impaired in schizophrenia 
(Leeson et al. 2009; McKirdy et al. 2009; Murray et al. 2008; Waltz and Gold 
2007) and has been recommended by CNTRICS for studying executive 
function in animal models of schizophrenia (Gilmour et al. 2013).  First, rats 
learn to discriminate between an S+ and S- by perceptually discriminating 
between S+ and S- and learning the reward contingency. Once the subject 
has acquired the discrimination, the reward contingency is reversed (S+ 
becomes the S-).  The reversal stage requires the subject to inhibit 
responding to the previously rewarded stimulus, and switch to the new reward 
contingencies.  
Reversal learning ability is dependent on the orbitofronal cortex 
(Bissonette et al. 2008; Burke et al. 2009; Chudasama and Robbins 2003) 
and striatum (Ragozzino 2007; Ragozzino et al. 2002).  Previous studies have 
found impairments in reversal learning in schizophrenia (McKirdy et al. 2009; 
Murray et al. 2008; Schlagenhauf et al. 2014; Waltz and Gold 2007), which 
are present following correction for IQ (Leeson et al. 2009), consistent with 
hypofrontality in schizophrenia. 
 
Methods 
 
 Apparatus:  Rat touchscreen chambers were the same as those used 
in previous touchscreen studies (McAllister et al 2013; Bussey et al 2008; 
Talpos et al 2010).  The object recognition Y-maze apparatus was the same 
as used by Forwood et al. (2005) and Winters et al. (2004). Three identical 
copies were used of each object with no natural significance or previous 
presentation. 
 Surgery:  mPFC lesions generally followed the adaptation of Birrell and 
Brown’s protocol (2000), used in previous touchscreen studies centred on 
prelimbic and infralimbic cortex (McAllister et al 2013). Bilateral injections of 
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0.2µL of 0.06M ibotenic acid (Sigma, UK) or vehicle were made at AP +3.5, L 
±0.6, V -5.2; AP+ 2.5, L ±0.6, V -5.0mm, relative to skull surface Bregma via 
custom infusing line and 10µL Hamilton syringe and Harvard Instruments 
Pump 11 (Holliston, Massachusetts) pump.  Subjects recovered for at least 
one week with ad libitum food and water prior to behavioural testing. 
 Histology:  Protocol followed previous touchscreen studies of lesions 
centred on mPFC (McAllister et al 2013).  Coronal sections (60 µm) were 
stained with NeuN and lesion locations were mapped onto standardized 
sections of the (Paxinos and Watson 2007) atlas of the rat brain. 
 Subchronic Phencyclidine Protocol:  Rats were dosed with 5mg/kg 
PCP (Sigma, UK) via intraperitoneal injection (5mg/ml) or 1ml/kg vehicle twice 
daily (7:30am/pm) for seven days, followed by a seven-day washout period 
prior to behavioural testing. 
 Touchscreen Testing Protocol:  Rats were group-housed on a reverse 
light-dark schedule (light 7pm-7am) and tested during dark phase.  A 
restricted diet maintained rats at no less than 85% of free-feeding weight, with 
water available ad libitum.  Pretraining touchscreen use prior to object-
location or reversal learning tasks followed established protocols (Bussey et 
al. 2008; Horner et al. 2013; McAllister et al 2013).  This experiment was 
conducted in accordance with the United Kingdom Animals (Scientific 
Procedures) Act, 1986. 
  
Object-location learning (Experiment 1) 
 scPCP treatment: 16 male 250-275g Lister Hooded rats were obtained 
from Harlan, UK.  After completion of pretraining rats were pseudorandomly 
allocated to PCP or vehicle treatment groups.  Following scPCP protocol rats 
completed two days of ‘punish for incorrect’ pretaining at criterion levels 
before PAL acquisition.  PAL acquisition generally followed protocols 
established by Talpos et al (2009) with the exception that rats were tested 
twice daily over 11 blocks of 5 sessions each.  
 mPFC lesions: 16 male 250-275g Lister Hooded rats were obtained 
from Harlan, UK.  Behavioural methods were initially identical to those in 
Experiment 1 scPCP, but as a difference between groups was observed, 
testing was extended to 17 blocks to explore the persistence of the deficit.  
Following acquisition of dPAL, an object-location challenge took place: the foil 
stimulus was replaced with the correct stimulus for all trials (sPAL protocol; 
Talpos et al., 2009; figure 1).  
 Behavioural testing: In this task three images are used as objects, each 
correct when presented in one of three response locations, and incorrect 
when presented in either of the other two. There are six unique trial types of 
one object in its correct location and a different foil object in an incorrect 
location (the ‘dPAL’ version of the task; Talpos et al 2009, figure 1). Talpos et 
al (2009) demonstrated that pharmacological manipulations of the 
hippocampus could impair performance of PAL, consistent with human 
imaging studies showing the hippocampus activated during encoding and 
parahippocampal gyrus during retrieval of the CANTAB PAL task (de Rover et 
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al. 2011). Dependency on mPFC has not previously been investigated. In this 
first experiment, we tested the effects of scPCP on the touchscreen PAL test. 
 
  
Fig. 1 Trial-types in touchscreen object-location paired-associates learning 
(dPAL left and sPAL right).  S+ rewarded; S- results in ‘time out’.  Adapted 
from Talpos et al (2009). 
 
Object recognition (Experiment 2) 
 The same scPCP and mPFC rats were used as in Experiment 1 and 
maintained under the same housing conditions.  Experiment 2 took place 
immediately following PAL acquisition, with initial habituation beginning the 
day following the last session of PAL. 
Three daily 5-minute habituation sessions followed by two sets of 
discriminations with novel object, order and novel side counterbalanced.  
Discrimination trials consisted of 3-minute exposure to 2 copies of the same 
object (sample phase), delay, then 3-minute choice phase with a third copy of 
the pre-exposed object and a novel object.  The apparatus and objects were 
wiped down with a dilute ethanol solution between trials to prevent olfactory 
trails.  A minimum of 20 seconds exploration during sample phase was 
required for analysis, defined as nose oriented towards the object within 2cm.  
Discrimination scores  were calculated for the total time as 
well as the first minute.  
In addition, this experiment allowed testing of the persistence of the 
functional effects of scPCP, as it is conceivable that the lack of effect of 
scPCP on PAL in Experiment 1 was due to the effects of scPCP decreasing 
over time. Indeed, longitudinal testing of the effects of scPCP post-washout is 
not common, with most testing taking place fewer than seven days post-
washout.  Thus we tested the same rats used in Experiment 1 on 
spontaneous object recognition at 2 time-points: 40 and 105 days post-
washout.  
 
Reversal learning (Experiment 3) 
 32 male 250-275g Lister Hooded rats were obtained from Harlan, UK 
and housed as in PAL protocol, above. 
 Behavioural testing took place in the touchscreen chambers used in 
Experiment 1, with screen masking adapted for 2 choices.  Acquisition 
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7 
consisted of daily 1 hour sessions of up to 100 trials until all subjects reached 
stable criterion of greater than 80% across 3 consecutive days.  Subjects 
were pseudorandomly assigned to treatment groups, counterbalancing for 
performance.  All rats immediately re-baselined at criterion and reversal 
began on day 4 post-washout/11 post-lesion. Maximum session length was 
100 trials or 1 hour, with the first session split into shorter sessions of 25, 25, 
and 50 trials (one session/day) to ensure completion of trials (summed to 
session 1).  Rats were tested for 18 sessions. 
 
Results 
 
Experiment 1: Effects of scPCP on acquisition of the PAL task 
Repeated-measures ANOVA did not demonstrate a significant effect of 
scPCP in acquisition of object-location paired-associates learning (F(1-14)= 
0.675, p=0.43) and both groups reached 80% correct by block 11.  At this 
point, rats moved on to Experiment 2.  Log transformed reaction times 
significantly decreased across acquisition (F(2.37,33.12)= 16.31, p<0.001) with 
no significant effect of scPCP (F(1, 14)= 0.89, p= 0.361).  Magazine latency 
also decreased across acquisition (F(10,14)= 2.67, p= 0.005), with no significant 
effect of scPCP (F(1,14)= 0.11, p=0.92). 
 
 
Fig. 2 Effects of scPCP on acquisition of PAL.  Blocks of 5 sessions are 
plotted.  Error bars ±1 SEM.     
 
Experiment 1: mPFC Dysfunction and PAL Acquisition 
 Histological results: Histology confirmed lesions of the medial prefrontal 
cortex in all rats, centred on the prelimbic and infralimbic cortices with 
damage to overlying anterior cingulate cortex.  Shams did not show significant 
damage to any of those regions.  One lesion was excluded from data analysis 
as largely unilateral, resulting in 8 sham and 7 lesions. 
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Fig. 3 mPFC lesions in PAL.  
Damage common to all subjects in 
solid black, with maximum extent 
of any damage shown by the black 
line.  Coronal sections at 3.72mm, 
2.76mm, and 1.08mm anterior to 
Bregma.  Images adapted from Paxinos and Watson 
(2007).  Composite photomicrograph presents contrast 
between sham (left) and lesion (right) for demonstration 
purposes. 
 
 
 
 
 Behavioural results:  Repeated measures ANOVA demonstrated 
significant main effect of lesion (F(1,12)= 5.01, p=0.045) and session block 
(F(7.87,54)= 63.8, p<0.001), with no interaction (F(7.87,54)= 1.74, p=0.099).  
Performance appeared to asymptote slightly below 90% correct for shams, 
and 80% correct for lesions (no significant learning over blocks 17-19: shams 
(F(2,12)= 0.25, p=0.78; lesion F(2,12)= 0.23, p=0.80).  Response latencies 
reduced over the course of acquisition (F(7.42,81.6)= 1.94, <0.001), with no 
significant difference between sham and lesion ( F(1,11)= 1.46, p=0.25 or 
latency to magazine (F(1,11)= 0.32, p=0.86). 
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Fig. 4 Effects of mPFC 
dysfunction on acquisition of PAL 
and sPAL object-location 
challenge.  Blocks of 5 sessions 
are plotted.  Error bars ±1 SEM.  
*= p<0.05 (S-N-K).  A significant 
difference in standard deviation of 
performance between trial-types 
during PAL acquisition.   
 
 
During the mPFC object-location challenge, there was no significant 
difference in performance between dPAL and sPAL for sham (t(12)=0.46, 
p=0.65) or lesion (t(12)=0.59, p=0.56), suggesting both groups used an object-
location strategy (rather than, e.g., a conditional strategy).   The lesion group 
was impaired on both sPAL and dPAL (dPAL t(12)=3.05, p=0.01; sPAL 
t(12)=2.14, p=0.044).  To further probe the nature of task acquisition, analysis 
of individual trial types was then undertaken. 
 Analysis showed different rates of learning of each trial-type-- not 
unexpected, as it is likely an animal would, for various reasons, work out 
some of the object-location bindings before others.  Interestingly, however, 
initial examination by trial-type across acquisition found greater variance in 
the lesion group versus shams, suggesting that the lesion group had not fully 
solved all of the object-location paired-associates.  
 To quantify this variability we calculated, for each rat, mean standard 
deviation on each of the 6 trial types throughout acquisition (figure 4).  There 
was a significant effect of block (ANOVA F(8.4,108)=2.94, p<.01) and a 
significant lesion x block interaction (F(8.4,108)=2.53, p=0.01) as the sham group 
learned to perform all trial-types with greater proficiency, whereas the rats in 
the lesion group learned some trial types but not others. 
 
Experiment 2: scPCP and Object Recognition  
 Both 1 minute and 3 minute discrimination scores showed significant 
decrease in preference for the novel object in the scPCP group at six but not 
fifteen weeks post-washout (figure 5).  There was no significant difference 
between sham and lesion in overall exploration time during sample or choice 
at six weeks (sample t(12)=0.086, p= 0.51; choice t(12)= 0.82, p= 0.43).  scPCP 
significantly impaired novel object recognition at a 1 hour delay compared to 
vehicle t(12)= 2.55, p< 0.01, with the scPCP discrimination score not 
significantly greater than chance (t(6)=1.69, p=0.14). 
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Fig. 5 ScPCP and object recognition 40 and 105 days post-washout. Means 
of first minute discrimination scores. ±1SEM. *=p <0.01. 
 
Re-testing three months (105 days) post washout found no impairment 
in scPCP at a 1 hour or 24 hour delay (figure 5; 1 hour t(12)= 0.05, p= 0.95; 24 
hour t(12)= 0.07 p= 0.92), and no difference in exploration time (1 hour sample: 
t(12)=1.21, p= 0.25, choice: t(12)= 1.43, p= 0.18; 24 hour sample t(12)=0.74, p= 
0.47, choice t(12)= 0.32, p= 0.75). 
 
Experiment 2: mPFC Dysfunction and Object Recognition 
 1 minute and 3 minute discrimination scores showed no significant 
difference between lesion and sham rats at 1 hour or 24 hour delays (1 hour 
t(12)=1.51, p= 0.62, t(.02)= 0.98 or 24 hour t(12)=0.93, p= 0.37, t(12)=0.55, p= 
0.60). 
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Fig. 6 mPFC dysfunction and object recognition. Means of first minute 
discrimination scores. ±1SEM. 
 
  There were no significant differences in exploration time in sample or 
choice phase at a 1 hour (sample: t(12)=1.53, p= 0.15; choice: t(12)= 0.78, p= 
0.45) or 24 hour delay (sample: t(12)= 0.52, p= 0.61; choice: t(12)=1.03, 
p=0.32).  Discrimination scores at the 24 hour delay were significantly greater 
than chance for both sham and lesion (sham t(6)=4.51, p=0.004; lesion t(6)= 
3.14, p=0.016). 
 
Experiment 3: scPCP and Reversal Learning 
scPCP rats were significantly faster to reach the reversal learning 
criterion (80% accuracy over 2 consecutive sessions) than control rats both in 
errors to criterion (t(14)= 1.78, p=0.048) and sessions to criterion (t(14)= 1.95, 
p=0.035). 
 Performance across days of acquisition (figure 7) revealed a significant 
main effect of drug treatment on overall accuracy (F(1,10)= 5.2, p= 0.046) and 
number of correction trials (F(1,10)= 6.4, p= 0.03) but no drug x session 
interactions (accuracy F(8.09, 80.9)= 0.58, p= 0.77, correction trials F(3.91, 39.2)= 
0.95, p= 0.44).  
 
 
 
 
Fig. 7 Effects of scPCP on reversal learning acquisition, sessions and errors 
to criterion.  Means ±1 SEM. *= p<0.05. 
 
Analysis was also conducted in terms of stage of reversal, through 
early sessions (sessions 1-2), and mid-late sessions (considering sessions 3-
6 and 7-18 independently gave the same results as pooling). There was no 
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significant difference in accuracy or number of correction trials in early trials 
(accuracy F(1,13)= 0.068, p=0.799; correction trials F(1,14)= 2.11, p= 0.17), but 
the effect of scPCP on accuracy was significant through mid-late sessions 
(F(1,10)= 4.93, p=0.041).  Analysis of the perseveration index, the ratio of 
correction trials to initially incorrect responses, showed no significant 
difference overall (F(1,10) = 1.17, p= 0.30) or in early sessions (F(1,10) = 4.62, p= 
0.067) between sham and lesion. 
 A significant effect of drug treatment on log transformed response 
latency was seen in early sessions (F(1,10)= 5.71, p= 0.038) with vehicle rats 
initially responding significantly more rapidly.  This initial difference was not 
observed through later sessions F(1,10)= 4.23, p=0.67) and there was no 
significant drug x session interaction F(5.89,70.74)=1.74, p=0.60).  No significant 
effect of drug was seen on log transformed magazine latency in early 
sessions (F(1,10)= 0.20, p=0.664), late sessions (F(1,10)= 2.03, p=0.184), or 
overall (F(1,10)= 1.79, p= 0.210).   
 
Experiment 3: mPFC Dysfunction and Reversal Learning 
Histological results: Analysis of histology confirmed lesions of the 
medial prefrontal cortex in all rats, centred on the prelimbic cortex, with 
damage to the infralimbic cortex and overlying anterior cingulate (figure 8.  
Sham animals did not show damage to any of those regions, and one 
lesioned animal was excluded due to more unilateral lesion than common. 
 
Fig. 8 mPFC lesions in reversal 
learning.  Damage common to all 
subjects in solid black, with 
maximum extent of any damage 
shown by the black line.  Coronal 
sections taken at 3.72mm, 
2.76mm, and 1.08mm anterior to Bregma.  Images 
adapted from Paxinos and Watson (2007).  Composite 
photomicrograph presents a contrast between sham 
(left) and lesion (right) for demonstration purposes. 
 
 
 
 
 
 Behavioural results:  Rats were rebaselined for three sessions of the 
original discrimination post-surgery, which all subjects completed at criterion 
level (>80%).  mPFC rats were significantly faster in number of sessions 
required to reach the reversal learning criterion (t(12)=2.52, p=0.013), and also 
showed a near-significant reduction in the number of errors to criterion 
(t(12)=1.71, p=0.056). 
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Fig. 9 Effects of mPFC lesions on reversal learning; errors and sessions to 
criterion.  Means ±1 SEM. *= p<0.05. 
 
 Analysis of accuracy over the course of reversal found no significant 
effect of lesion during early trials (F(1,11)= 4.18, p= 0.086), mid trials (3-6) 
F(1,11)= 4.12, p= 0.067), late trials (7-18)  F(1,11)= 2.57, p= 0.14) or across mid-
late sessions (F(1,11)= 3.2, p= 0.10).  There was no significant difference in 
number of correction trials in early trials only (F(1,11)= 0.53, p= 0.48) or mid-
late trials only (F(1,11)= 2.22, p=0.16).  
The perseveration index showed no significant effect of lesion 
(F(1,10)=0.44, p= 0.52).  There was no difference in reaction time (F(1,11)= 
0.074, p= 0.79) with reaction time decreasing as the reversal progressed 
(F(7.7,84.9)= 34.1, p< 0.001).  There was no effect of lesion on magazine latency 
(F(1,11)= 0.001, p= 0.98) with latency roughly remaining constant as the 
reversal progressed in both groups (F(1.23,13.53)= 4.01, p=0.059). 
 
Discussion 
 
 There was a double-dissociation between object-location paired-
associates learning and object recognition: mPFC dysfunction impaired 
acquisition of the object-location task, but not spontaneous novel object 
recognition, while scPCP impaired spontaneous novel object recognition, but 
not object-location associative learning. Both scPCP and mPFC dysfunction 
resulted in a similar facilitation during the late stages of reversal learning.  
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 scPCP mPFC Lesion 
Object-Location Paired-Associates 
Learning: Acquisition 
No effect Impairment 
Object-Location Paired-Associates 
Learning: Motivation/Latencies 
No effect No effect 
Object Recognition: Discrimination Impairment No Effect 
Object Recognition: Exploration No effect No effect 
Reversal Learning Facilitation Facilitation 
Table 1 Cognitive profiles of scPCP and mPFC lesions generated in the 
present study. 
 
Object-location learning (Experiment 1) 
Whereas most tests of cognitive function following scPCP are 
conducted immediately post-washout, observed impairments on object 
recognition following PAL acquisition indicate the lack of effect of scPCP on 
PAL was not due to a decrease in general efficacy of the manipulation across 
time.  
Previous studies have suggested that scPCP can impair object-location 
learning.  For example, 5mg/kg scPCP induced a deficit in rats’ ability to 
simultaneously associate object-place-context (O-P-C) to identify novel 
objects (Le Cozannet et al. 2010).  That task, however, relies on one-trial 
spontaneous object recognition (known to be impaired following scPCP, see 
below).  This lower-order failure could underlie the observed impairment in 
other studies of object-location learning.   
 While a significant main effect of lesion was observed, the effect of the 
lesion manifests as a selective impairment in the later stages of acquisition.  
To investigate further how this task is solved, and thus perhaps illuminate the 
impairment seen following mPFC dysfunction, we carried out an object-
location challenge (‘sPAL’; Talpos et al 2009). With only six unique trial types 
it is conceivable that animals were responding to trial types as a whole picture 
or scene (a ‘gestalt’) rather than individual objects situated in individual 
locations, perhaps applying conditional rules by trial type. 
Correct object-location associations should result in completion of 
sPAL with little difficulty, whereas a strategy based on the combination of 
objects presented during the trial would not work.  Analysis showed no 
impairment in either group switching to sPAL, suggesting that both sham and 
lesion groups were not using a ‘gestalt’ trial-type strategy. The mPFC group 
was still impaired relative to sham, and their performance on sPAL dropped 
roughly the same amount (but not to chance). This pattern suggests that the 
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residual performance of mPFC lesioned group was due to some preserved 
object-location learning, but that this learning was not a rapid as in controls. 
In addition, analysis of variability in performance across trial types was 
quite revealing: in sham animals, performance on the different trial-types was 
highly variable during first sessions, then appeared to briefly converge, before 
performance across all trial types increased more uniformly.  This pattern may 
reflect a transition from an ‘elemental’ strategy, or perhaps stimulus bias 
(responding preferentially to particular stimuli), to an object-location 
configural/associative solution.  
Interestingly, the PFC-lesioned rats showed a very different pattern of 
performance (figure 4).  Like shams, rats in the PFC group appear to have 
approached the task with an elemental strategy or stimulus bias (indicated by 
the high variability across trial types during initial acquisition). The variance 
then decreases as rats relinquish this strategy or bias. Thereafter, however, 
performance differs markedly: whereas the sham animals’ performance 
increases and the trial-type variance decreases, the mPFC rats’ performance 
increases little and the variance remains the same. This pattern of results, 
and the pattern obtained in the sPAL probe analysis, suggest that in the later 
stages of PAL acquisition, rats master object-location associations, and that 
mPFC dysfunction impairs the ability to progress through this stage of the 
task. The idea that mPFC dysfunction impairs object-location binding is 
consistent with previous reports (Barker et al. 2007; Barker and Warburton 
2011). 
 
Object Recognition (Experiment 2) 
 scPCP treatment produced a robust impairment on object recognition 
in keeping with previous studies (Arnt et al. 2010; Grayson et al. 2014; 
Grayson et al. 2007; Horiguchi et al. 2011; Snigdha et al. 2010; Snigdha et al. 
2011).  This impairment is not the result of general differences in the 
exploration of objects, as evidenced by the roughly equal exploration times 
during the sample phase. The effects of scPCP treatment were shown to be 
surprisingly long-lasting, affecting SOR 40 days post washout. However, the 
effects of scPCP was also time-limited, with no effect at even a 24 hour delay 
after 105 days. A caveat is that this comparison is made within-subject, 
without a between-subject control for order of testing. However it seems 
unlikely that the substantial difference between effects of scPCP at 40 and 
150 days was due to this factor alone.     
  The neurobiological changes underlying this impairment remain 
unclear, and myriad effects are observed following scPCP treatment (Egerton 
et al. 2005; Neill et al. 2010; Neill et al. 2014).  In particular, studies have 
shown that scPCP treatment downregulates striatal D1 and upregulates 
cortical 5-HT1A receptor binding in rats (Choi et al. 2009).  Investigation of the 
amelioration of scPCP-induced impairments in novel object recognition 
implicate these mechanisms, as the D1 receptor agonist asenapine 
ameliorates a scPCP-induced impairment in object recognition, unless co-
treated with the D1 antagonist SCH-23390 (Snigdha et al. 2011).  Co-
administration of atypical antipsychotics with PCP prevent development of 
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novel object recognition deficits (Oyamada et al. 2015).  Further studies with 
D1 agonists (McLean et al. 2009) or atypical antipsychotics (Grayson et al. 
2007) have also demonstrated amelioration of impairments in object 
recognition.  Additionally, the 5-HT6 receptor antagonist Lu AE58054 has 
been shown to rescue scPCP induced impairment in object recognition (Arnt 
et al. 2010).  
 A lack of effect of mPFC lesions on object recognition is in keeping the 
literature published on various forms of spontaneous object recognition 
(Barker et al. 2007; Ennaceur et al. 1997; Hannesson et al. 2004).  
 
A double-dissocation between object-location learning and object recognition 
 The effects of scPCP dissociated across tasks: while scPCP did not 
impair object-location paired-associates learning, it did impair spontaneous 
object recognition.  This may appear paradoxical, as object recognition could 
seem to be required for paired-associates learning (for example, lesions to the 
perirhinal cortex impaired both object recognition and an object-in-place task 
(Barker and Warburton 2011), although perirhinal cortex lesions have not 
been tested with the touchscreen PAL task used here). However the repeated 
exposure to trial types and gradual learning in touchscreen paired-associates 
learning may be a fundamental difference between these tasks.  Unlike object 
recognition, which is regarded (rightly or wrongly; Bussey et al. 2013) as one-
trial learning, PAL was learned across sessions over many days. Perirhinal 
cortex dysfunction can impair discrimination learning across sessions in the 
touchscreen (Winters et al. 2010), although the photographic stimuli used in 
that study were more complex than those used here, and it has been shown 
that perirhinal lesions can impair complex, but not simple discriminations 
(Bussey et al. 2003).  Another possibility is that scPCP affected structures 
other than perirhinal cortex that are important for object recognition, for 
example mediodorsal thalamus (Aggleton and Mishkin 1983; Mumby et al. 
1993). 
 The effects of mPFC cortex dysfunction were also observed to 
dissociate across tasks, but in the opposite direction: lesions impaired PAL, 
but not object recognition. This likely reflects the higher order nature of the 
PAL task, which requires integrating information about object and location. 
This interpretation is consistent with the findings of Barker et al (2007), who 
report impairment following PFC dysfunction on an object-location task (but 
not on simpler object or location recognition tasks).  
Thus, Experiments 1 and 2 demonstrate a double dissociation between 
scPCP and PFC dysfunction on PAL and object recognition tasks. The object 
recognition data show that scPCP affects structures outside the PFC that are 
important for object recognition. More surprisingly, perhaps, the PAL 
experiments show that if scPCP induces mPFC dysfunction, it is not of 
sufficient magnitude to mimic the impairments found after excitotoxic mPFC 
dysfunction on this task. 
 
Reversal learning (Experiment 3) 
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 Rodent models of schizophrenia have often demonstrated impaired 
acquisition, impaired reversal, and/or increased perseveration in various 
testing paradigms (Brigman et al. 2006 & 2008; Zhuo et al. 2007). In contrast, 
in the present experiment, scPCP facilitated performance during the later 
sessions of reversal.  scPCP-treated animals did not display any differences 
from vehicle-treated animals when performing below 50% correct, indicating 
that increased perseveration is not resulting from the scPCP treatment. 
 While certain other models of schizophrenia have not displayed 
increased perseveration (e.g., Brigman et al. 2008), they have shown 
impaired learning of the new S+ v S- contingency.  However, scPCP 
treatment did not impair acquisition or reversal of a visual discrimination in 
mice (Brigman et al. 2009) or rats (Fellini et al. 2014).  Unlike these previous 
studies, in the present study performance during late reversal was actually 
facilitated, with PCP-treated rats reaching asymptote at a higher level of 
performance than their vehicle treated controls. However, selective late-stage 
facilitation has been previously observed in touchscreen reversal learning 
conducted under similar conditions. In mice, both mild stress and 
ventromedial prefrontal cortex lesions selectively facilitated late reversal 
(Graybeal et al. 2011).  The authors note that in other studies chronic stress 
can promote habit-like responding in rats (coupled with atrophy of mPFC and 
the ‘associative’ striatum and hypertrophy of the ‘sensorimotor’ striatum, as in 
(Dias-Ferreira et al. 2009).  Indeed, lesions of the dorsolateral striatum 
impaired touchscreen reversal in mice; see Graybeal et al (2011) 
supplementary materials.  The effects of scPCP might be understood using a 
similar explanation: dysfunction of the vmPFC removes inhibition on the 
dorsolateral striatum and thus facilitates striatal-mediated habit formation late 
in the reversal. However combined with the results from Experiment 1, such 
an explanation suggests that mPFC dysfunction induced by scPCP was 
sufficient to facilitate transition to habit, but insufficient to produce an 
impairment in PAL. Alternatively, other mechanisms such as direct 
disinhibition of the striatum might underlie the scPCP-induced improvement. 
 Like scPCP treatment, and consistent with previous studies, mPFC 
dysfunction did not impair reversal learning (Boulougouris et al. 2007; 
Chudasama et al. 2001) and indeed, according to sessions and errors to 
criterion, significantly facilitated it.  Visual inspection indicates that like scPCP, 
facilitation appears in the late, but not the early, perseverative stage of 
reversal.  A difference between the pattern of data in the two experiments is 
that the (sham-lesioned) control rats eventually reached the same 
performance level as the mPFC-lesioned rats, whereas the vehicle-treated 
rats never quite reached the same level as the scPCP-treated rats.  There 
was also more variability in the mPFC lesion group than there was in the 
scPCP-treated group. Taking these considerations into account, and the 
uncommon pattern of late reversal facilitation in both experiments, we 
conclude that the effects of scPCP and mPFC dysfunction were similar. 
However neither manipulation looks like what one would expect from a 
‘complete’ model of schizophrenia, in which reversal learning is, if anything, 
impaired (Leeson et al. 2009; Murray et al. 2008; Waltz and Gold 2007). 
That mPFC dysfunction did not produce impairment in touchscreen 
reversal learning is consistent with previous literature (Bussey et al., 1997; 
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although impairments were obtained with perceptually difficult stimuli). 
Previously, dissociations have been observed between regions of the 
prefrontal cortex: orbitofrontal cortex lesions impair reversal learning, while 
mPFC lesions impair attentional set shifting (Bissonette et al. 2013; Dias et al. 
1996).  Indeed, ventromedial prefrontal cortex (vmPFC) lesions in mice led to 
a late facilitation similar to that observed here (Graybeal et al. 2011).  Coupled 
with the finding that BDNF infusions into the vmPFC prevent reversal 
facilitation by stress, and the effects of striatal lesions, Graybeal et al 
proposed a mechanism whereby vmPFC dysfunction disinhibits habit 
formation by striatal systems (see discussion of Experiment 3 above, 
(Graybeal et al. 2011).  A similar mechanism may underlie the late facilitation 
seen in the scPCP-treated rats, and/or the trend toward facilitation shown by 
the mPFC-lesioned rats, in the present study.   
 
Evaluating scPCP as a Model for Schizophrenia 
The use of phencyclidine to model schizophrenia has received some 
criticism (Brigman et al. 2010; Domino and Luby 2012). As schizophrenia is 
characterized by hypofunction of the prefrontal cortex (Andreasen et al. 1992; 
Carter et al. 1998; Glahn et al. 2005; Hill et al. 2004), in the present 
experiments we asked the specific question of whether the cognitive 
impairments following scPCP resemble those following mPFC dysfunction.  
These findings may be useful to consider when choosing a rodent model for 
studies into schizophrenia, particularly if importance is placed on the model 
faithfully reproducing the effects of mPFC dysfunction. Considering each of 
the three tasks in turn: 
Object-location learning: Although scPCP had no effect on PAL, 
schizophrenic patients are impaired on the CANTAB version of PAL (Bartok et 
al. 2005). Great caution must be taken, however, in using this contrast alone 
to conclude that scPCP is a poor model, as we do not yet have a complete 
idea to what extent rodent PAL and CANTAB-PAL depend on the same 
psychological and neural mechanisms.  Although some evidence suggests 
they do, for example performance of rodent PAL and CANTAB-PAL both 
involve the hippocampus (de Rover et al. 2011; Owen et al. 1995; Talpos et 
al. 2008; Kim et al., this issue) and mutations in the schizophrenia-related 
gene dlg2 can lead to impairments in both rodent PAL and CANTAB-PAL 
(Nithianantharajah and Grant 2013).  However, scPCP did not replicate the 
effects of mPFC dysfunction on this task. 
Object Recognition: scPCP clearly and reproducibly impaired OR. Thus 
scPCP combined with SOR may be a good model for testing schizophrenia-
relevant cognitive enhancers. However the lack of effect of mPFC dysfunction 
on OR suggests that the effect of scPCP was not due to dysfunction of the 
mPFC. Furthermore, a caveat regarding the use of SOR is that it has been 
argued that schizophrenics are not impaired on familiarity-based item 
recognition as measured by SOR, but are impaired only when recollective 
processes are required (Huron et al. 1995; van Erp et al. 2008). 
Reversal learning: Schizophrenic patients are impaired on touchscreen 
reversal learning, yet scPCP in the present experiment not only did not impair 
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reversal learning, it facilitated switching to the new contingency.  Other 
researchers have similarly observed a lack of impairment following scPCP on 
touchscreen reversal learning (Brigman et al. 2009; Fellini et al. 2014) and in 
attentional set-shifting paradigms (Egerton et al. 2005; McLean et al. 2012; 
Rodefer et al. 2005 & 2008).  Thus to the extent that researchers wish a 
model to recapitulate the impairments in reversal learning seen in 
schizophrenia, scPCP may not be the best choice. It should be noted, 
however, that reversal impairments following scPCP have been observed 
using other methodology, for example in operant chambers (Abdul-Monim et 
al. 2007; Idris et al. 2010; McLean et al. 2009 & 2010  and in some studies 
using the bowl-digging version of the task (Dawson et al. 2010; however cf. 
Egerton et al. 2005 & 2008; McLean et al. 2008 & 2012; Pedersen et al. 2009; 
Rodefer et al. 2005 & 2008).  
To conclude, there was a double-dissociation between scPCP and 
mPFC dysfunction on object-location paired associates learning and object 
recognition, yet similar effects on reversal learning.  The pattern of impairment 
following scPCP raises questions around its efficacy as a model of cognitive 
impairment in schizophrenia, particularly if importance is placed on the model 
faithfully reproducing the effects of mPFC dysfunction. 
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Fig. 1 Trial-types in touchscreen object-location paired-associates learning (dPAL left and sPAL right).  S+ 
rewarded; S- results in ‘time out’.  Adapted from Talpos et al (2009).  
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Page 29 of 37 Psychopharmacology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
Fig. 1 Trial-types in touchscreen object-location paired-associates learning (dPAL left and sPAL right).  S+ 
rewarded; S- results in ‘time out’.  Adapted from Talpos et al (2009).  
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Fig. 3 mPFC lesions in PAL.  Damage common to all subjects in solid black, with maximum extent of any 
damage shown by the black line.  Coronal sections at 3.72mm, 2.76mm, and 1.08mm anterior to 
Bregma.  Images adapted from Paxinos and Watson (2007).  Composite photomicrograph presents contrast 
between sham (left) and lesion (right) for demonstration purposes.  
41x73mm (300 x 300 DPI)  
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Fig. 3 mPFC lesions in PAL.  Damage common to all subjects in solid black, with maximum extent of any 
damage shown by the black line.  Coronal sections at 3.72mm, 2.76mm, and 1.08mm anterior to 
Bregma.  Images adapted from Paxinos and Watson (2007).  Composite photomicrograph presents contrast 
between sham (left) and lesion (right) for demonstration purposes.  
41x27mm (300 x 300 DPI)  
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Fig. 8 mPFC lesions in reversal learning.  Damage common to all subjects in solid black, with maximum 
extent of any damage shown by the black line.  Coronal sections are taken at 3.72mm, 2.76mm, and 
1.08mm anterior to Bregma.  Images adapted from Paxinos and Watson (2007).  Composite 
photomicrograph presents a contrast between sham (left) and lesion (right) for demonstration purposes.  
41x79mm (300 x 300 DPI)  
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Fig. 8 mPFC lesions in reversal learning.  Damage common to all subjects in solid black, with maximum 
extent of any damage shown by the black line.  Coronal sections are taken at 3.72mm, 2.76mm, and 
1.08mm anterior to Bregma.  Images adapted from Paxinos and Watson (2007).  Composite 
photomicrograph presents a contrast between sham (left) and lesion (right) for demonstration purposes.  
41x31mm (300 x 300 DPI)  
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